Keyphrases
Abl Kinase
16%
Anticancer Drugs
16%
Bronchoalveolar Lavage
33%
Bronchoalveolar Lavage Fluid
91%
Cell Lysate
16%
Cellular Disruption
16%
Cellular Processes
16%
Chronic Obstructive Pulmonary Disease
26%
Coagulation
33%
Control Status
13%
Cystic Fibrosis
66%
Distance Discrimination
18%
Endogenous Substrates
33%
Enzyme-linked Immunosorbent Assay (ELISA)
16%
Fibrosis Diseases
33%
Fluids Samples
54%
Forced Expiratory Volume in 1 Second (FEV1)
16%
HIV-associated
66%
Host-microbe
33%
Human Cells
33%
Inflammatory Biomarkers
33%
Intracellular Environment
16%
Kinase Activity
16%
Living Cells
16%
Lower Airways
33%
Lung
33%
Lung Function Decline
33%
Lung Proteome
33%
Mass Spectrometry
60%
Mass Spectrometry Analysis
28%
Matched Case-control
13%
Metabolomics
66%
Metatranscriptomics
33%
Multi-omics
33%
Network Analysis
33%
Obstructive Lung Disease
66%
Optimised Workflow
33%
People Living with HIV (PLHIV)
66%
Peptide Substrate
33%
Phospho-specific Antibodies
16%
Phosphorylation
16%
Plasma Metabolomics
38%
Pneumoproteins
33%
Protein Expression
16%
Quantitative Proteomics
33%
Strategic Timing
13%
Treatment Group
13%
Tyrosine Kinase
16%
Tyrosine Kinase Activity
16%
Tyrosine Phosphorylation
33%
Biochemistry, Genetics and Molecular Biology
Amino Acids
8%
Anticancer
16%
Aptamer
11%
Bacterial Load
12%
Bacterial Peptide
6%
Cell Lysate
16%
Cystic Fibrosis
66%
Dynamics
33%
Enzyme
16%
Forced Expiratory Volume
16%
Human Immunodeficiency Virus
100%
Infectious Agent
7%
Kinase
16%
Lipid
8%
Liquid
83%
Liquid Chromatography-Mass Spectrometry
7%
Mass Spectrometry
45%
Mass Spectrometry
9%
Metabolite
37%
Metabolome
79%
Metabolomics
43%
Microbiome
12%
Microorganism
33%
Monospecific Antibody
33%
Peptide Sequence
10%
Phosphatidylcholine
5%
Phosphotransferase
16%
Protein Expression
16%
Proteome
33%
Proteomics
24%
Quantitative Proteomics
33%
Random Forest
8%
Receptor Tyrosine Kinase
16%
Smoking
5%
Tandem Mass Spectrometry
13%
Taxon
7%
Tyrosine
16%
Tyrosine Kinase
16%
Tyrosine Phosphorylation
33%
